HUP0401161A2 - Lerkanidipin-hidroklorid szolvátjai és lerkanidipin-hidroklorid új kristályos formái, eljárás előállításukra és a kristályos formákat tartalmazó gyógyászati készítmények - Google Patents
Lerkanidipin-hidroklorid szolvátjai és lerkanidipin-hidroklorid új kristályos formái, eljárás előállításukra és a kristályos formákat tartalmazó gyógyászati készítményekInfo
- Publication number
- HUP0401161A2 HUP0401161A2 HU0401161A HUP0401161A HUP0401161A2 HU P0401161 A2 HUP0401161 A2 HU P0401161A2 HU 0401161 A HU0401161 A HU 0401161A HU P0401161 A HUP0401161 A HU P0401161A HU P0401161 A2 HUP0401161 A2 HU P0401161A2
- Authority
- HU
- Hungary
- Prior art keywords
- lercanidipine hydrochloride
- crystalline forms
- solvates
- preparation
- pharmaceutical compositions
- Prior art date
Links
- WMFYOYKPJLRMJI-UHFFFAOYSA-N Lercanidipine hydrochloride Chemical compound Cl.COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)CN(C)CCC(C=2C=CC=CC=2)C=2C=CC=CC=2)C1C1=CC=CC([N+]([O-])=O)=C1 WMFYOYKPJLRMJI-UHFFFAOYSA-N 0.000 title abstract 5
- 229960002162 lercanidipine hydrochloride Drugs 0.000 title abstract 5
- 239000012453 solvate Substances 0.000 title abstract 4
- 238000002360 preparation method Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000004807 desolvation Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A találmány lerkanidipin-hidroklorid szerves oldószerekkel alkotott újszolvátjaira, az említett szolvátokból nyert lerkanidipin-hidrokloridúj kristályos (III) és (IV) formájára, a lerkanidipin-hidrokloridemlített szolvátja, valamint (III) és (IV) formája előállításieljárására deszolvatálással, valamint a kristályos (III) és (IV) formalegalább egyikét tartalmazó gyógyászati készítményekre vonatkozik. Ó
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2001MI001727A ITMI20011727A1 (it) | 2001-08-06 | 2001-08-06 | Solvati della lercanidipina cloridrato e nuove forme cristalline della lercanidipina cloridrato ottenute da essi |
| PCT/EP2002/008700 WO2003014085A1 (en) | 2001-08-06 | 2002-08-05 | Solvates of lercanidipine hydrochloride and new crystalline forms of lercanidipine hydrochloride |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0401161A2 true HUP0401161A2 (hu) | 2004-09-28 |
| HUP0401161A3 HUP0401161A3 (en) | 2009-04-28 |
Family
ID=11448246
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0401161A HUP0401161A3 (en) | 2001-08-06 | 2002-08-05 | Solvates of lercanidipine hydrochloride and new crystalline forms of lercanidipine hydrochloride, process for their preparation and pharmaceutical compositions containing the crystalline forms |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1423367B1 (hu) |
| JP (1) | JP2005502648A (hu) |
| KR (1) | KR100912664B1 (hu) |
| CN (1) | CN100494175C (hu) |
| AR (1) | AR037230A1 (hu) |
| AT (1) | ATE294162T1 (hu) |
| AU (1) | AU2002331390B2 (hu) |
| BR (1) | BR0211738A (hu) |
| DE (1) | DE60203919D1 (hu) |
| EA (1) | EA200400279A1 (hu) |
| ES (1) | ES2209684T1 (hu) |
| HR (1) | HRP20040157A2 (hu) |
| HU (1) | HUP0401161A3 (hu) |
| IL (2) | IL153916A0 (hu) |
| IT (1) | ITMI20011727A1 (hu) |
| MX (1) | MXPA04001073A (hu) |
| NO (1) | NO20040479L (hu) |
| PE (1) | PE20030350A1 (hu) |
| PL (1) | PL369449A1 (hu) |
| UY (1) | UY27409A1 (hu) |
| WO (1) | WO2003014085A1 (hu) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100651212B1 (ko) | 2004-10-27 | 2006-12-01 | 제일약품주식회사 | 무정형 레르카니디핀의 제조방법 |
| AR052918A1 (es) | 2005-02-25 | 2007-04-11 | Recordati Ireland Ltd | Clorhidrato de lercanidipina amorfo |
| KR20080048065A (ko) * | 2005-09-16 | 2008-05-30 | 그렌마크 파머수티칼스 엘티디. | 다형 형태의 염산 레르카니디핀 및 이것의 제조방법 |
| US20100104649A1 (en) * | 2007-03-05 | 2010-04-29 | Actavis Group Ptc Ehf | Lercanidipine Hydrochloride Polymorphs and an Improved Process for Preparation of 1,1,N-Trimethyl-N-(3,3-Diphenylpropyl)-2-Aminoethyl Acetoacetate |
| WO2008136394A1 (ja) * | 2007-04-27 | 2008-11-13 | Ajinomoto Co., Inc. | ラクタム化合物の製造方法及びその製造中間体 |
| EA027787B1 (ru) | 2010-06-23 | 2017-09-29 | Крка, Товарна Здравил, Д.Д., Ново Место | Пероральные лекарственные формы, содержащие лерканидипин и эналаприл и их фармацевтически приемлемые соли |
| EA023996B1 (ru) | 2010-12-24 | 2016-08-31 | КРКА, д.д., НОВО МЕСТО | Гомогенные фармацевтические пероральные лекарственные формы, содержащие лерканидипин и эналаприл или их фармацевтически приемлемые соли совместно с органической кислотой |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8403866D0 (en) * | 1984-02-14 | 1984-03-21 | Recordati Chem Pharm | Diphenylalkylaminoalkyl esters |
| US5912351A (en) | 1995-05-12 | 1999-06-15 | Recordati, S.A. Chemical And Pharmaceutical Company | Anhydrous 1,4-Dihydropyridines and salts thereof |
-
2001
- 2001-08-06 IT IT2001MI001727A patent/ITMI20011727A1/it unknown
-
2002
- 2002-08-02 AR ARP020102957A patent/AR037230A1/es not_active Application Discontinuation
- 2002-08-05 AU AU2002331390A patent/AU2002331390B2/en not_active Ceased
- 2002-08-05 CN CNB028155114A patent/CN100494175C/zh not_active Expired - Fee Related
- 2002-08-05 BR BR0211738-0A patent/BR0211738A/pt not_active IP Right Cessation
- 2002-08-05 AT AT02767318T patent/ATE294162T1/de not_active IP Right Cessation
- 2002-08-05 WO PCT/EP2002/008700 patent/WO2003014085A1/en active IP Right Grant
- 2002-08-05 ES ES02767318T patent/ES2209684T1/es active Pending
- 2002-08-05 DE DE60203919T patent/DE60203919D1/de not_active Expired - Lifetime
- 2002-08-05 IL IL15391602A patent/IL153916A0/xx unknown
- 2002-08-05 PL PL02369449A patent/PL369449A1/xx unknown
- 2002-08-05 JP JP2003519035A patent/JP2005502648A/ja active Pending
- 2002-08-05 EA EA200400279A patent/EA200400279A1/ru unknown
- 2002-08-05 EP EP02767318A patent/EP1423367B1/en not_active Expired - Lifetime
- 2002-08-05 MX MXPA04001073A patent/MXPA04001073A/es not_active Application Discontinuation
- 2002-08-05 KR KR1020047001791A patent/KR100912664B1/ko not_active IP Right Cessation
- 2002-08-05 HU HU0401161A patent/HUP0401161A3/hu unknown
- 2002-08-06 PE PE2002000716A patent/PE20030350A1/es not_active Application Discontinuation
- 2002-08-06 UY UY27409A patent/UY27409A1/es not_active Application Discontinuation
-
2003
- 2003-01-13 IL IL153916A patent/IL153916A/en unknown
-
2004
- 2004-02-03 NO NO20040479A patent/NO20040479L/no not_active Application Discontinuation
- 2004-02-18 HR HR20040157A patent/HRP20040157A2/hr not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE294162T1 (de) | 2005-05-15 |
| ITMI20011727A0 (it) | 2001-08-06 |
| CN1538958A (zh) | 2004-10-20 |
| HUP0401161A3 (en) | 2009-04-28 |
| EA200400279A1 (ru) | 2004-06-24 |
| MXPA04001073A (es) | 2005-02-17 |
| UY27409A1 (es) | 2003-03-31 |
| AR037230A1 (es) | 2004-11-03 |
| ES2209684T1 (es) | 2004-07-01 |
| JP2005502648A (ja) | 2005-01-27 |
| DE60203919D1 (de) | 2005-06-02 |
| PL369449A1 (en) | 2005-04-18 |
| IL153916A (en) | 2008-07-08 |
| EP1423367A1 (en) | 2004-06-02 |
| CN100494175C (zh) | 2009-06-03 |
| KR20040030932A (ko) | 2004-04-09 |
| HRP20040157A2 (en) | 2004-08-31 |
| AU2002331390B2 (en) | 2008-06-05 |
| NO20040479L (no) | 2004-02-03 |
| BR0211738A (pt) | 2004-09-28 |
| WO2003014085A1 (en) | 2003-02-20 |
| IL153916A0 (en) | 2003-07-31 |
| KR100912664B1 (ko) | 2009-08-17 |
| ITMI20011727A1 (it) | 2003-02-06 |
| PE20030350A1 (es) | 2003-06-06 |
| EP1423367B1 (en) | 2005-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0402043A2 (hu) | Rimonabant polimorf formája, eljárás ezen forma előállítására és ilyen polimorf formát tartalmazó gyógyászati készítmények | |
| NO20085077L (no) | Nye forbindelser | |
| NO20082330L (no) | Nye krystallinske polymorfe former av lerkanidipinhydroklorid og fremgangsmate for fremstilling derav | |
| MXPA05009985A (es) | Ligandos de receptores de canabinoides. | |
| TW200613243A (en) | Novel compounds | |
| SE0302192D0 (sv) | Novel compounds | |
| MXPA03001431A (es) | Polimeros de un analogo de epotilona. | |
| NO20043101L (no) | Farmasoytiske blandinger av oralt aktive taxanderivater som har forsterket biotilgjenglighet | |
| EA200701687A1 (ru) | Гидрохлорид аморфного лерканидипина | |
| ATE386725T1 (de) | Heterocyclylverbindungen | |
| HUP0300701A2 (hu) | Zolpidem hemitartarát, eljárás az előállítására és ezt tartalmazó gyógyszerkészítmények | |
| HUP0200580A2 (hu) | Celecoxib polimorf kristályos formái, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| WO2004093800A3 (en) | Thyronamine derivatives and analogs and methods of use thereof | |
| DE60217843D1 (de) | Ein dioxinoä2,3-güchinolin-9-carbonsäure derivat als nk3 rezeptor antagonist | |
| HUP0301713A2 (hu) | Propenonszármazékokat tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| HUP0401080A2 (hu) | Új görcsoldó sószármazékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| HUP0401161A2 (hu) | Lerkanidipin-hidroklorid szolvátjai és lerkanidipin-hidroklorid új kristályos formái, eljárás előállításukra és a kristályos formákat tartalmazó gyógyászati készítmények | |
| NO20055835D0 (no) | Cykliske aminderivater, fremgangsmater for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
| IL157540A (en) | Pharmaceutical compositions comprising n-(aryl)-2-arylethenesulfonamides, some such novel compounds and process for their preparation | |
| HUP0303737A2 (hu) | 6-helyzetben szubsztituált indolinonok és alkalmazásuk kináz inhibitorokként, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| HUP0301082A2 (hu) | Új polimorf olanzapine hidroklorid sók, eljárás ezek előállítására, az ezeket tartalmazó gyógyászati készítmények és felhasználásuk | |
| HUP0401895A2 (hu) | Paroxetin N-formil származékai, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| HUP0400776A2 (hu) | N-(Metiletilaminokarbonil)-4-(3-metilfenilamino)-3-piridilszulfonamid és gyűrűs oligoszacharidok kompozíciói, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| HUP0204297A2 (hu) | (-)-cisz-2-(2-Klór-fenil)-5,7-dihidroxi-8-[4R-(3S-hidroxi-1-metil)-piperidinil]-4H-1-benzopirán-4-on etanolos szolvátja, eljárás az előállítására és ezeket tartalmazó gyógyszerkészítmények | |
| WO2005049632A8 (en) | Bifunctional macrolide heterocyclic compounds and methods of making and using the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |